Article: The Right Tool for the Job: An Overview of Hsp90 Inhibitors.
Advances in experimental medicine and biology
2020 Volume 1243, Page(s) 135–146
Abstract: Molecular chaperones are responsible for maintaining intracellular protein quality control by facilitating the conformational maturation of new proteins as well as the refolding of denatured proteins. While there are several classes of molecular ... ...
Abstract | Molecular chaperones are responsible for maintaining intracellular protein quality control by facilitating the conformational maturation of new proteins as well as the refolding of denatured proteins. While there are several classes of molecular chaperones in the cell, this chapter will focus solely on the small molecule modulation of Hsp90, the 90 kDa heat shock protein. Hsp90 is not only responsible for folding nascent proteins, but it also regulates the triage of numerous client proteins through partnering with the ubiquitin-proteasome pathway. Consequently, Hsp90 plays critical role in maintaining the protein homeostasis (proteostasis) network within the cell and is required for the activation/maturation of more than 300 client protein substrates. Many of the clients that depend upon Hsp90 are overexpressed or mutated during malignant transformation. This often renders the clients thermodynamically unstable and dependent on Hsp90 for stability. This phenomenon results in an oncogenic 'addiction' to the Hsp90 protein folding machinery as Hsp90 maintains onco-client proteins. Furthermore, Hsp90-dependent substrates are associated with all ten hallmarks of cancer, making Hsp90 an attractive target for the development of cancer chemotherapeutics. In fact, 17 small molecule inhibitors of Hsp90 have been developed and clinically evaluated for the treatment of cancer. Unfortunately, most of these molecules have failed for various reasons, necessitating a new approach to modulate the Hsp90 protein folding machine. |
---|---|
MeSH term(s) | Animals ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; HSP90 Heat-Shock Proteins/antagonists & inhibitors ; HSP90 Heat-Shock Proteins/metabolism ; Humans ; Neoplasms/drug therapy ; Neoplasms/metabolism ; Protein Folding/drug effects |
Chemical Substances | Antineoplastic Agents ; HSP90 Heat-Shock Proteins |
Language | English |
Publishing date | 2020-04-15 |
Publishing country | United States |
Document type | Journal Article ; Review |
ISSN | 2214-8019 ; 0065-2598 |
ISSN (online) | 2214-8019 |
ISSN | 0065-2598 |
DOI | 10.1007/978-3-030-40204-4_9 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.